Shah Ends Novavax Proxy Fight Following Sanofi Deal
Law 360
MAY 20, 2024
Hedge fund Shah Capital Management Inc. told fellow Novavax Inc. shareholders Monday that it is ending its fight to remove certain members of the biotech company's board, citing its favorable view of Novavax's licensing deal with Sanofi earlier this month.
52 
Let's personalize your content